Wouter Meuleman is a seasoned professional in the life sciences and genomics sectors, currently serving as a Board Observer at Precede Biosciences, where the focus is on advancing precision medicine through blood analysis. As a Partner at Illumina Ventures, Meuleman invests in early-stage companies that innovate in nucleic acid sequencing and genomics. With various board member roles at companies such as RedShiftBio, Lightcast Discovery, Fluent BioSciences, Ribometrix, and Biota Technology, Meuleman actively contributes to advancing technologies in molecular analysis and therapeutic development. Previous experience includes a directorial position in Corporate and Business Development at Illumina and scientific roles that established a strong foundation in chemical engineering and chemistry, supported by degrees from leading universities including the University of Cambridge and Newcastle University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices